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Studies of Pancreatic Carcinogenesis
in Different Animal Models
by Dante G. Scarpelli,* M. Sambasiva Rao* and
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Pancreatic carcinomas can be induced in rat, guinea pig and hamster by a variety of carcinogens. The
types ofneoplasms which arise vary with the species ofrodent. In the rat, they consist exclusively ofacinar
cells, in the other species the lesions are adenocarcinomas resembling those derived from pancreatic
ductules and ducts, those in hamster more so than in guinea pigs. Careful sequential studies in the guinea
pigand hamster suggest that acinarcells togetherwith ductular and duct cells are involved in the genesis of
duct adenocarcinomas. In each rodent model, the acinar cell appears to be quite sensitive to continued
exposure to carcinogen. In each instance, acini undergo modulation, and in the guinea pig and hamster,
permanent metaplastic transformation to ductlike structures. Such cells assume an enhanced capacity for
cell proliferation which persists following cessation of carcinogen treatment. Other studies suggest that
adult pancreatic acinar cells possess a surprising degree of plasticity. Their involvement in the
pathogenesis of neoplasms resembling pancreatic ducts is not unlike other carcinogenic sequences where
extensive cell modulation and metaplasia precede and are an integral partofthe neoplastic transformation.
Introduction
In recent years there has been considerable progress
in experimental pancreatic carcinogenesis research in-
volving basically three rodent animal models, the rat,
guinea pig and Syrian golden hamster. Initial carcino-
genesis studies involved implantation of 7,12-dimethyl-
benzanthracene (DMBA) crystals (1) or DMBA in dex-
trose pellets (2) into the pancreas of Sprague-Dawley
rats. Pancreatic adenocarcinomas consisting of acinar
cells developed, on the average, in about 200 days
following implantation. Later workers administered
carcinogenic substances such as 4-hydroxyaminoquino-
line-i-oxide (4HAQO), a carcinogenic metabolite of
4-nitroquinoline-1-oxide (3), azaserine (4), and the hypo-
lipidemic drugs, nafenopin (5) and clofibrate (6,7), and
N5-(N-methyl-N-nitrosocarbamoyl)-L-ornithine (MNCO),
a methylnitrosourea amino acid (8), systemically, and
induced both acinar cell adenomas and adenocarci-
nomas. Although the rat model has been quite useful,
the pancreatic neoplasms they develop do not resemble
those that constitute the most common type encoun-
tered in humans, namely ductal adenocarcinomas. In
the case of the guinea pig, pancreatic adenocarcino-
mas were induced by the prolonged administration of
N-methyl-N-nitrosourethane (MNUT) (9) in drinking
water, or N-methyl-N-nitrosourea (MNU) by intra-
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gastric gavage weekly for 28 weeks or more (10). A
variety of N-nitrosamines derived from 13-oxidation of
N,N-dipropylnitrosamine induced pancreatic ductal ade-
nocarcinomas in the Syrian golden hamster. Chemically
induced pancreatic cancer in both species are morpho-
logically and biologically quite similar to those of man
(10-17). These various models are summarized in Table
1. The studies to be reviewed in this communication will




in Various Rodent Species
Rat and Guinea Pig
In both the rat and guinea pig, the pancreatic acinar
cell appears to be singularly susceptible to carcinogene-
sis regardless ofthe carcinogen employed. Three differ-
ent carcinogens-4HAQO, (a hydroxylated metabolite
of4-nitroquinoline-l-oxide), DMBA (a polycyclic hydro-
carbon), and azaserine (a diazoketone)-all induce
acinar cell adenomas and carcinomas in rat pancreas.
Since the lesions induced by these carcinogens appear
to be strikingly similar (1,3-5), if not identical, the
histogenetic sequence that follows may be considered as
applying to all of them. The lesions begin as localizedSCARPELLI, RAO AND REDDY
Table 1. Animal models of chemically induced pancreatic carcinoma.
Route of Dosage of Carcinomas
Species Carcinogen administration carcinogen induced Reference
Rat DMBA Intrapancreatic 2-10 mg(?)a Acinar (1,2)
implant
4HAQO IV 6-13 mg/kga Acinar (3)
Azaserine IP 5 mg/kge Acinar (4)
Nafenopin Diet 0.1% (wt/wt)b Acinar (5)
Clofibrate Diet 0.1% (Wt/Wt)b Acinar (6,7)
MNCO IP 10-20 mg/kgc Acinar (8)
Guinea pig MNUT In drinking water 2.5 mg/kgd Adenocarcinoma (9)
MNU Gavage 10 mg/kgc Adenocarcinoma (10)
Hamster BHP SC 250-500 mg/kgc Ductal (11)
BAP SC 17.5-20 mg/kg Ductal (12)
BOP SC 10-30 mg/kgc Ductal, rare acinar (13)
HPOP SC 9-40 mg/kg' Ductal (14)
MOP SC 1.75-3.5 mg/kgc Ductal (15)





nests ofaciniwhich undergo hyperplastic growth. When
these are microscopic in size, they are described as
"foci;" larger lesions which are grossly visible, measur-
ing 1 to 10 mm in diameter, are referred to as "nodules."
Acinar cells in foci and nodules, regardless oftheir size,
are uniformly cytologically abnormal. Their nuclei are
larger and more basophilic than those ofnormal acinar
cells; except for this alteration, the cells appear normal
in every other respect, including a full complement of
zymogen granules. In larger nodules, acinar cells
showed a somewhat greater degree of nuclear and
nucleolar variability, as well as mitotic activity. Ultra-
structurally, zymogen-rich cells in foci and nodules
showed a normal complement of cell organelles and
zymogen granules which were morphologically identical
to those in normal acinar cells.
The classification of large nodules as adenomas is
based more on their apparent potential for semiautono-
mous growth rather than objective cytologic criteria.
Large nodules and adenomas are usually not encap-
sulated. The diagnosis of acinar cell adenocarcinoma
and probable carcinomas is based on either decreased
acinar cell differentiation (Fig. 1) or evidence of
extrapancreatic spread or both. Metastases occur both
in highly differentiated zymogen granule laden acinar
cell tumors as well as poorly differentiated tumors that
bear little to no resemblance to their cell of origin.
Recentfindings (18) suggest thatthehistogenesis and
pathogenetic sequence of acinar cell tumors may be
more complex than previously thought. It turns out
that a hitherto unidentified acinar cell variant appears
during the pathogenesis of acinar cell tumors-the
so-called basophilic cell. In contrast to zymogen-rich
acinar cells which stain with the acidophilic component
of hematoxylin eosin stain, the basophilic cells do not
FIGURE 1. Transplantable rat pancreatic acinarcellcarcinomashow-
ing moderately differentiated acini containing zymogen granules.
x320.
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differences as documented in Table 2. Pilot unpublished
experiments aimed at elucidating the sequence oftheir
development suggest that between 8 and 12 weeks after
IV injection of 4HAQO there is a marked proliferation
ofbasophilic acinar cells which leads to the formation of
foci which then appear to lose their capacity for growth
and become quiescent. By contrast, 4HAQO-induced
acidophilic cells show a capacity for increased growth
which apparently persists as these evolve from foci to
nodules and, finally, to adenocarcinomas. Our prelimi-
nary results suggest that the cells which comprise
basophilic foci may be endstage cells which may not
4HAQO
ACINAR CELL _ _ _ _BASOPHILIC FOCI -END STAGE CELL C?)
ACIDOPHILIC FOCI--._w- ACIDOPHILIC NODULES--ACINAR CELL CARCINOMA
FIGURE 3. Developmental sequence ofacinarcellcarcinomashowing
(-) established and (--) possible pathways and relationships.
FIGURE 2. 4HAQO-induced basophilic focus (arrow) adjacent to an
eosinophilic nodule. x 190.
Table 2. Mitotic index and nuclear labeling of normal pancreas
and acidophilic and basophilic foci following a single dose of
4-hydroxyaminoquinoline-1-oxide.
Labeled nuclei
Tissue Mitotic index per 1000 cells
Normal pancreas 0 1±1
Acidophilic foci 2.75±1.27 23.2±3.15
Basophilic foci 0.125 1.2±1.2
bind eosin to a significant degree because they contain
few, and more rarely moderate, numbers of zymogen
granules (Fig. 2). At the level of ultrastructure, the
remainder ofcytoplasmic constituents are bothmorpho-
logically as well as quantitatively indistinguishable from
those in normal pancreatic acinar cells. The nucleus is
parabasal, enlarged andirregularwithanormalchroma-
tin pattern and contains a large nucleolus. Mitoses are
quite rare in acinar cells in basophilic foci. Studies to
quantitate and compare cell replication in acidophilic
and basophilic foci, and acidophilic nodules to adjacent
normal pancreas established that there were significant
FIGURE 4. Pseudoductular change involving acinar cells in the pan-
creas of a guinea pig treated with the carcinogen 4HAQO.
Numerous nuclei labeled with [3H]-thymidine indicate increased
DNA synthesis in altered acinar cells. x 190.
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participate in acinar cell carcinogenesis (Fig. 3). Other
alternatives are that they represent a quiescent acinar
cell pool which may, under proper conditions, enter the
proliferating pool and become involved in the develop-
ment of tumor. The precise significance of basophilic
acinar cell foci and their relation to acinar cell cancer
remains unknown.
A second feature ofacinarcellcarcinogenesis whichis
both unexpected and interesting is a modulation of
acinar cells to phenotypes that morphologically closely
resemble ductular elements of the pancreas. Such
changes have been encountered in the rat with DMBA
(1,2), azaserine (4), and in the guinea pig with 4HAQO
and MNU (10). 4HAQO, nafenopin, clofibrate and
MNCO apparently do notinduce the development ofthe
ductular phenotype from acinar cells in the rat. The
changes consist of dilatation of acini which progresses
with continued exposure to carcinogen and is accompa-
nied by shedding ofapical cytoplasm and variable loss of
zymogen granules (Fig. 4). These alterations begin
early and persist throughout tumorigenesis. They may
be sufficiently pronounced so that definitive diagnosis of
the neoplasms as acinar in origin may be difficult,
leading some investigators to comment and speculate on
their histogenesis (1,2,4,). The changes which have
beenvariouslyreferredtoaspseudoductular ordediffer-
FIGURE 5. Moderately well-differentiated adenocarcinoma induced
by MNU in guinea pig pancreas. x 180.
entiation clearly represent a stable cell modulation in
response to carcinogen. In the guinea pig, ductular
morphology of the carcinomas is more consistent and
marked than in the rat, and in this respect, closely
resembles true ductular and ductal adenocarcinomas
(Fig. 5). However, their acinar cell derivation is appar-
ent by the presence of zymogen granules in precursor
lesions including severely atypical ones (10,19). Their
involvementandultimatefateinpancreaticcarcinogene-
sis in the guinea pig is not entirely established because
the chemically induced pancreatic carcinomas do not
appear to retain the capacity to synthesize and store
zymogen granules.
Hamster
In the hamster, exposure to pancreaticotropic N-ni-
trosamines leads to the development ofductal adenocar-
cinomas almost exclusively. Their histogenesis appear
to be somewhat more complex than pancreatic cancer in
the rat and guinea pig and have been the subject of
much study and controversy. Before beginning on the
details ofthe development ofchemically induced ductal
carcinomas in the hamster, it should be noted that in
contrast to the situation with the carcinogens which
induce pancreatic cancer in the rat, much is known
FIGURE 6. Well-differentiated ductal adenocarcinoma of hamster
pancreas. x 140.
222PANCREATIC CARCINOGENESIS MODELS
FIGURE 7. Intraductal adenocarcinoma of a medium-size duct in
hamster pancreas showing cribiform pattern of epithelial pro-
liferation. x270.
about the metabolism ofthose that are carcinogenic for
hamster pancreas (20-31). The initial and most detailed
histologic descriptions ofN-nitrosamine inducedpancre-
atic carcinomas in hamsters document that they are
adenocarcinomas (Fig. 6) that closely resemble the
ductular and ductal pancreatic cancers of humans
(32-35). Sequentialstudiesofhistogenesis(35,36), which
are essentially in agreement, identified a number of
early lesions which appeared first in common duct
epithelium consisting of hypertrophy, hyperplasia and
metaplasia. As these progress, the lesions become
papillary, often filling the lumen. Eventually, such
epithelial lesions evolve into in situ, and invasive
adenocarcinomas. A similar sequence is also observed
in the main and secondary pancreatic ducts (Fig. 7).
Ductular lesions consist of proliferative epithelium
which undergo increasing atypia and finally neoplastic
transformation with coalescence into malignant multi-
ductular complexes. In one study (35), proliferation of
islets, and the consistent appearance ofductules within
and around them were identified (Fig. 8). These duct-
ules eventually underwent malignant change. In a
subsequent communication (37) considerable emphasis
is placed onthe role ofislets in the genesis ofpancreatic
FIGURE 8. Intra and perinsular cystadenomatous ductal prolifera-
tion in hamster pancreas following chronic administration of
BOR x 110.
Table 3. Uptake of14C-HPOP by isolated islets and acinar cells of
hamster pancreas and its competitive inhibition by 3H-3-OMG.
Uptake, pmole "4C-HPOP/mg protein/30 mina
Concentra- % Acinar %
Compound tion, mM Islets Inhibition cells Inhibition
'4C HPOP 5 966.99 987.90
14C HPOP + 5
3H 3-OMG 5 787.38 18.57 679.18 31.25
14C HPOP + 5
3H 3-OMG 10 553.62 42.7 311.77 68.44
a Each value is the mean of two separate experiments.
ductal adenocarcinoma in the hamster. It has been
suggested that the response of islets to the pancreatic
carcinogens BOP, BHP and DMNM is through the
common metabolite HPOP' (21,22). This is presumably
because HPOP exists in two tautomeric forms, one of
which is cyclic, closely resembling the pyranose form of
hexose sugars (22), whichisthoughttobe preferentially
bound and taken up by islets in contrast to other
pancreatic cells. Recent studies in our laboratory inves-
tigated this possibility. A comparison of 14C-HPOP
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uptake by isolated islets with that of acinar cells from
hamster pancreas, and the competitive effect of3H-3-0-
methyl glucose (3H-3-OMG), an analog ofglucose which
is not metabolized, are shown in Table 3. The results
show that the uptake of HPOP by islet cells is equal to
that by acinar cells. HPOP uptake by acinar cells is
inhibited about 1.6 times more by 3-OMG than is its
uptake by islet cells. Although competitive inhibition by
3-OMG supports the notion that HPOP probably enters
both islet and acinar cells by the same transport
mechanism as does glucose, there appears to be no
evidence for its preferential uptake by islet cells. An
elegant study (38) in which 3HDMNM was localized in
hamster pancreas by ultrastructural autoradiography
has shown label in both acinar and duct epithelial cells.
In subsequent experiments (30) we corroborated and
extended these findings by demonstrating that all the
component cells of pancreas can metabolize DMNM,
and that acinar and islet cells do not differ quantita-
tively in their capacity to do so. The following, when
coupled to the fact that islet cells represent only about
1.7% of the total cell population of rodent pancreas as
contrasted with 82% for acinar cells (39), tends to lessen
the probability that islet cells are important in pancre-
atic carcinogenesis. An attempt (40) to establish that
FIGURE 9. Pseudoductules arising from acini in hamster pancreas 3
weeks after administration of 50 mg/kg of DMNM. x270.
ductular cells are highly sensitive to the carcinogenic
effects ofBOP was unfortunately not entirely successful
because as is well known (35) it is difficult, if not
impossible, to clearly distinguish proliferating ductular
cells from ductal cells so that the resulting tumors
appear to be ductal regardless of their cell of origin.
Therefore, while intra- and perinsular ductules may be
involved in ductal carcinogenesis there is no clear or
compelling evidence that they are more important in
this regard than other component cells ofthe pancreas.
A facet of pancreatic carcinogenesis in the hamster
which has intrigued us was the early appearance of
pseudoductular change (Fig. 9) involving acinar cells
(36). The sequence ofmorphologic changes are identical
to those encountered in acinarcells ofrat and guinea pig
pancreas. As has been shown in the guinea pig (19),
these alterations are accompanied by enhanced DNA
synthesis and acinar cell replication. Although, some
acinar cell proliferation may be in response to cell death
due to the toxic effects ofthe carcinogen (42), it cannot
account for the sustained proliferation that is seen in
the hamster model during carcinogenesis (36,41). Their
augmented proliferation is probably due to theiradapta-
tion to the toxic and growth suppressive effects of
carcinogen, a phenomenon that has been well estab-
lished when cells are chronically exposed to carcino-
genic compounds (43,44). It is also noteworthy that
increased growth of acinar cells that have undergone
pseudoductular change continues long after treatment
with BOP has been stopped (36), suggesting that
although they are not yet neoplastic cells, they have
been significantly and perhaps irreversibly altered.
Further, their enhanced sustained replication renders
them much more sensitive to the effects ofcarcinogens
than more quiescent cells of the pancreas. Attempts in
ourlaboratorytounequivocallyestablishbymorphologic
means that pseudoductules derived from acini undergo
malignant change and become ductal adenocarcinoma
cells have not been unequivocally convincing. However,
recently a series of detailed and systematic studies
utilizing electron microscopy have clearly documented
that acinar cell-derived pseudoductules do ultimately
become malignant (45-47).
Thehistogenesis ofpancreatic cancer, asnoted earlier,
involves not only pseudoductules derived from acinar
cells which coalesce into adenocystic complexes that
subsequently undergo malignant change, but also the
epithelium lining the major pancreatic duct and its
Table 4. Peak [3H]-thymidine incorporation and mitotic index of
acinar, islet and ductal cells in regenerating hamster pancreas.
Acinara Isleta Ductala
[3H]-thymidine labeled 224 ± 25 23 ± 9.2 19 ± 7.5
nuclei/100 cellsb
Mitotic index 16.8 ± 5.0 1.8 ± 0.86 1.4 ± 0.6
mitoses/100 cells
a Values are means ± SE.
b [3H]-Thymidine incorporation 60 hr after initiation ofregeneration.
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branches. Thus, several somewhat different develop-
mental pathways appear to be operative in the genesis
ofductal adenocarcinoma in the hamster pancreas. One
pathway involves modulation of the highly differenti-
ated acinar cell to the less specialized ductular cell. In
the second, the duct cell is the direct target of the
carcinogen. In this regard, it should be noted that
carcinogen not only enters duct cells from the blood but
that they are also exposed to active forms of the
carcinogenpresentinthepancreaticjuice (21), presuma-
bly released from acinar cells. Recently we decided to
approach the question of histogenesis by exploiting an
interesting characteristic of pancreatic regeneration in
the hamster, namely that the bulk of the regenerative
response appears to be due to the proliferation ofacinar
cells (48). A comparison ofDNA synthesis as measured
by incorporation of 3H-thymidine in the various cells of
the pancreas during regeneration is shown in Table 4.
This is an excellent model with which to test whether
acinar cells are involved in the genesis of pancreatic
ductal cancer since the replicating acinar cells are much
more sensitive to the effects of a carcinogen. Accord-
ingly, BOP was injected 60 hr after regeneration was
initiated, when 22% ofacinar cells are in S phase ofthe
cell cycle, representing an almost synchronous wave of
DNA synthesis. Such treatment led to more than a 50%
increase in tumor incidence over that in a control group
in which an identical dose of BOP was administered to
animals in which pancreatic injury and subsequent
regeneration were not induced (49). Even more sig-
nificant is the fact that the most common lesions
encountered in the animals exposed to carcinogen
during pancreatic regeneration were acinar-derived
pseudoductules and cystadenomatous complexes, and
that the neoplasms induced were exclusively ductal
adenocarcinomas. It is noteworthy that these cancers
developed in animals in whom the cell at greatest risk
for carcinogenesis in the regenerating pancreas model
was the acinar cell.
Plasticity of Pancreatic Acinar
Cells
In the foregoing briefreview ofchemical carcinogene-
sis of the pancreas, the acinar cell has emerged as a
common denominator. In each of the rodent species
considered, the highly specialized acinar cell responds
to the injurious effects of carcinogen by changing to a
phenotype closely resembling the less differentiated
ductularcell. Inthe hamster, pseudoductules formquite
readily following even relatively minor damage such as
mild crush injury, and therefore may represent a
nonspecific reaction to sublethal damage. Although, the
long-term stability ofthe change remains to be unequiv-
ocally established, experimental evidence to date sug-
gests that it may be protracted. Pseudoductules in-
duced by crush injury have been found to persist for as
long as 3 months (Rao and Scarpelli, unpublished
observations). Conversions ofone celltype to anotherin
the adult organism are well documented and frequently
encountered in a variety ofpathologic conditions. Such
an alteration in differentiation is referred to as meta-
plasia, and almost always involves the conversion of a
highly specialized cell to a less specialized one. For
example, the change of mucus-secreting goblet cells in
bronchial epithelium to less specialized squamous epi-
thelial cells in the lungs of heavy smokers. Thus, the
conversion of an acinar cell to a ductular one should not
be surprising. It seems appropriate, therefore, to
consider pseudoductular formation as a metaplastic
change. However, acceptance ofthis possibilityhas been
slow because such a conversion goes counter to the
sequence that appears to be operative during embryo-
logical development of pancreas, namely that acini and
islets develop from pre-existing ducts.
An even more marked change in differentiation can be
induced by a single exposure of regenerating hamster
pancreatic acinar cells to BOP In this instance, acinar
cells undergo transformation to liver cells which are
stable and, once induced, remain for the lifetime ofthe
animal (50). These cells possess many ofthe characteris-
tics of adult hepatocytes such as light and ultrastruc-
tural morphology, synthesis of glycogen and albumin,
peroxisome proliferation and synthesis of associated
enzymes following exposure to hypolipidemic agents,
induction of aryl hydrocarbon hydroxylase by pheno-
barbital, cell proliferation following subtotal hepatec-
tomy and iron accumulation with the administration of
excessive iron dextran (51,52). In an effort to establish
the pancreatic cell from which hepatocytes originate,
acinar cell atrophy was induced by ligation of one of
three segments ofthe hamster pancreas. In this model,
ducts and islets in the ligated segment remain relatively
unchanged. Animals prepared in this way were sub-
jected to the protocol for induction of hepatocytes in
pancreas. Liver cells were induced in the normal
segments of the pancreas but were absent in the
atrophic one-strong support that the hepatocytes are
derived by redirected differentiation of acinar cells
(unpublished observations, Scarpelli and Rao.)
The induction of hepatocytes from adult acinar cells
raises some interesting questions about gene stability
and expression in the adult state. Current dogma holds
that in embryonic development, cells lose their exten-
sive potentialities and become fixed to a specific path-
way of differentiation known as determination (53-55).
Although determination occurs at different times dur-
ing development, it is generally considered to be fixed
relatively early. How then can an adult acinar cell,
presumably determined early in its developmental
history, undergo a complete switch of differentiation
and assume many of the structural and functional
characteristics ofan apparently differentiated livercell?
Since it apparently requires cell replication for the
change to occur, it may mean that switching off pan-
creas specific genes and activation of liver specific ones
can only occur when DNA is less condensed and
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exposed as it is in S phase ofthe cell cycle. Is it possible
that given the proper stimulus, any fully differentiated
cell can be induced to redirect its differentiation along a
new pathway? Finally, is the surprising plasticity and
ease with which adult acinar cells in hamsterand guinea
pig undergo pseudoductular formation related to the
absence of pancreatic acinar cell carcinomas in both
species? Since carcinogenesis results in a defect of
differentiation, it seems reasonable to study initiation
and regulation of differentiation in acinar cells which
appear to be an important target cell in pancreatic
carcinogenesis.
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